Jonathan Stelter 1, Kilian Weiss2, Lisa Steinhelfer3,4, Jakob Meineke5, Rickmer Braren1,4, Dimitrios Karampinos1,6,7
1Institute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany
2Philips GmbH Market DACH, Hamburg, Germany
3Institute for Diagnostic and Interventional Neuroradiology, School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany
4Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6CIBM Center for Biomedical Imaging, Lausanne, Switzerland
7Laboratory of Magnetic Resonance Imaging Systems and Methods, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Presenting Author: Jonathan Stelter
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of Liver Iron with MRI: State of the Art and Remaining Challenges. Journal of Magnetic Resonance Imaging 2014; 40:1003–1021. doi:10.1002/jmri.24584 [doi]
2. Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, Fleming KA, Cobbold JF, Robson MD, Neubauer S, Barnes E. Multiparametric Magnetic Resonance Imaging for the Assessment of Non-alcoholic Fatty Liver Disease Severity. Liver International 2017; 37:1065–1073. doi:10.1111/liv.13284 [doi]
3. Moura Cunha G, Navin PJ, Fowler KJ, Venkatesh SK, Ehman RL, Sirlin CB. Quantitative Magnetic Resonance Imaging for Chronic Liver Disease. The British Journal of Radiology 2021; 94. doi:10.1259/bjr.20201377 [doi]
4. Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J, Man K, Wu EX. Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis. Journal of Magnetic Resonance Imaging 2012; 36:152–158. doi:10.1002/jmri.23606 [doi]
5. Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, Tanabe K, Chung RT, Lauwers G, Chew ML, Boland GW, Sahani DV, Vangel M, Hahn PF, Caravan P. T2 Relaxation Time Is Related to Liver Fibrosis Severity. Quantitative Imaging in Medicine and Surgery 2016; 6:103–114. doi:10.21037/qims.2016.03.02 [doi]
7. Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP. T1 Mapping, T2 Mapping and MR Elastography of the Liver for Detection and Staging of Liver Fibrosis. Abdominal Radiology 2020; 45:692–700. doi:10.1007/s00261-019-02382-9 [doi]
8. Yang W, Kim JE, Choi HC, Park MJ, Choi HY, Shin HS,Won JH, Han F, Nickel MD, Cho HC. T2 Mapping in Gadoxetic Acid-Enhanced MRI: Utility for Predicting Decompensation and Death in Cirrhosis. European Radiology 2021; 31:8376–8387. doi:10.1007/s00330-021-07805-0 [doi]
9. Goldberg MA, Hahn PF, Saini S, Cohen MS, Reimer P, Brady TJ, Mueller PR. Value of T1 and T2 Relaxation Times from Echoplanar MR Imaging in the Characterization of Focal Hepatic Lesions. American Journal of Roentgenology 1993; 160:1011–1017. doi:10.2214/ajr.160.5.8470568 [doi]
10. Cieszanowski A, Szeszkowski W, Golebiowski M, Bielecki DK, Grodzicki M, Pruszynski B. Discrimination of Benign from Malignant Hepatic Lesions Based on Their T2-relaxation Times Calculated from Moderately T2-weighted Turbo SE Sequence. European Radiology 2002; 12:2273–2279. doi:10.1007/s00330-002-1366-6 [doi]
11. Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, Kaczynski B, Maj E, Gornicka B, Grodzicki M, Grudzinski IP, Stadnik A, Krawczyk M, Rowinski O. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. European Radiology 2012; 22:2514–2524. doi:10.1007/s00330-012-2519-x [doi]
12. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* Mapping Accurately Estimates Hepatic Iron Concentration in Transfusion-Dependent Thalassemia and Sickle Cell Disease Patients. Blood 2005; 106:1460–1465. doi:10.1182/blood-2004-10-3982 [doi]
13. Tamada D, Navaratna R, Weaver JM, Hernando D, Reeder SB. Whole Liver Phase-based R2 Mapping in Liver Iron Overload within a Breath-hold. Magnetic Resonance in Medicine 2025; doi:10.1002/mrm.30461 [doi]
14. Akçakaya M, Basha TA, Weingärtner S, Roujol S, Berg S, Nezafat R. Improved Quantitative Myocardial T2 Mapping: Impact of the Fitting Model. Magnetic Resonance in Medicine 2015; 74:93–105. doi:10.1002/mrm.25377 [doi]
15. Weidlich D, Schlaeger S, Kooijman H, Börnert P, Kirschke JS, Rummeny EJ, Haase A, Karampinos DC. T2 Mapping with Magnetization-prepared 3D TSE Based on a Modified BIR-4 T2 Preparation. NMR in Biomedicine 2017; 30:e3773. doi:10.1002/nbm.3773 [doi]
16. Stelter J, Weiss K, Steinhelfer L, Meineke J, Zhang W, Kainz B, Braren RF, Karampinos DC. Abdominal Simultaneous 3D Water T1 and T2 Mapping Using a Free-Breathing Cartesian Acquisition with Spiral Profile Ordering. Magnetic Resonance in Medicine 2025; doi:10.1002/mrm.70040 [doi]
17. Avants BB, Epstein CL, Grossman M, Gee JC. Symmetric Diffeomorphic Image Registration with Cross-Correlation: Evaluating Automated Labeling of Elderly and Neurodegenerative Brain. Medical image analysis 2008; 12:26–41. doi:10.1016/j.media.2007.06.004 [doi]